Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ActLight is a Swiss technology company specializing in the development of a new generation of CMOS-based photodiodes known as Dynamic PhotoDiodes (DPD). The company's proprietary technology offers significantly higher sensitivity and lower power consumption compared to traditional photodiodes, making it ideal for wearable healthcare devices. ActLight focuses on licensing its intellectual property for applications such as heart rate monitoring, pulse oximetry, and non-invasive glucose sensing. By enabling more accurate and energy-efficient physiological monitoring, the company aims to enhance the performance of consumer and medical-grade wearables. Their technology is designed to be easily integrated into standard semiconductor manufacturing processes, facilitating rapid adoption by global partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ActLight.